Tag Archives: Menopausal

Pilot Study of Neurosteroid Ganaxolone for Menopausal Depression

Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids.  This class of compounds are steroid hormones produced in the brain and endocrine tissues which can modulate neurotransmission.  Animal studies have demonstrated that neurosteroids have a broad range of activities, including antidepressant, anxiolytic, sedative, analgesic, anticonvulsant, neuroprotective,… Read More »

Menopausal weight gain whole food diet

Low testosterone can affect your libido and leave you feeling fatigued and depressed. Keeping track of food and weight. Additionally, hormone changes lead to declined bone density, which can increase your risk of fractures 5. Written by Melissa Groves on November 23, While menopause is linked to many uncomfortable symptoms and increases your risk of… Read More »

New Research Study: Pregnenolone Neurosteroid for the Treatment of Menopausal Depression

Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids.  This class of compounds are steroid hormones produced in the brain and endocrine tissues which can modulate neurotransmission.  Animal studies have demonstrated that neurosteroids have a broad range of activities, including antidepressant, anxiolytic, sedative, analgesic, anticonvulsant, neuroprotective,… Read More »

Women Taking Menopausal Hormone Therapy May Be More Resistant to Urine Infections: Study

Washington DC, July 18: In the first analysis of its kind, US-based doctors have shown that women who take menopausal hormone therapy (MHT, also known as HRT) have a greater variety of beneficial bacteria in their urine, possibly creating conditions that discourage urinary infections. The study also shows that women who suffer from recurrent urine… Read More »

Menopausal Depression is Common, Who Is at Risk?

Patients and clinicians may not be fully aware that women are at increased risk for depression during the menopausal transition.  The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians screen all adults for depression, highlighting the importance of screening in populations at particularly high risk for depression.  While these recommendations have prompted increased awareness… Read More »

Screening for Menopausal Depression: Are We Doing Enough?

Recent studies suggest that the burden of menopausal symptoms is greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase.  For many, the symptoms are manageable; however, a significant proportion of midlife women experience menopausal symptoms that negatively affect… Read More »